News Muncher - searching for source

3 months, 1 week ago

Drug regulator suspends manufacturing and selling of Entod pharma's eye drops over unapproved claims

The DCGI has halted the authorization given to Mumbai-based Entod Pharmaceuticals to produce and market its novel eye drops, citing the company's assertions that it can assist individuals with presbyopia in becoming less reliant on reading glasses. In response to the claim "first eye drop in India designed to reduce the need for reading glasses", the order stated that the …

India Order Company Eye Approved Presbyopia Dcgi

1 year, 10 months ago

DGCI issues notice to Amazon, Flipkart among other e-pharmacies over sale of drugs without license

India TV News

E-commerce giants Amazon and Flipkart were served show-cause notice along with 20 other online sellers by the Drugs Controller General of India regarding the sale of drugs without a licence. The show-cause notice dated February 8 by DCGI V G Somani cited a Delhi High Court order dated December 12, 2018, which prohibits online sales of medicines without a licence. …

Drugs Sale Amazon Notice Licence Flipkart Dcgi

1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

India Covid Dcgi Sii Covovax Booster Dose Heterologous Booster Dose

2 years ago

Indian-made cough syrups did not cause Gambia children deaths, DCGI informs WHO

India TV News

The Drugs Controller General of India has informed WHO that linking Indian-made cough syrups to deaths in Gambia was 'premature conclusion' which impacted the image of the country's pharmaceutical products across the globe. In the latest letter to Dr Rogerio Gaspar, Director at WHO, DCGI Dr V G Somani said a statement issued by the global health body in October …

India Deaths Indian Gambia Dcgi Somani Syrup

2 years, 2 months ago

Govt panel says information shared by WHO inadequate to determine reason for deaths linked to Gambia

India TV News

The committee set up by the government to examine reports potentially linking the death of 66 children in The Gambia to four made-in-India cough syrups has observed that the clinical information shared by the World Health Organization so far is inadequate to determine the aetiology. In an email response, Dr Somani on Saturday said the Union Ministry of Health has …

India Deaths Haryana Committee Received Cdsco Shared

2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

India Bharat Biotech

2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

India Vaccination Age Aged Serum 12 Years Dcgi

2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

India Covid Vaccine Booster Doses Dcgi Dose

2 years, 9 months ago

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

India TV News

Highlights Govt has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax. An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation …

India Trial Covid Singh Vaccine Permission Booster

2 years, 10 months ago

DCGI grants restricted EUA to COVID jab Corbevax for 12-18 age group

Deccan Chronicle

New Delhi/Hyderabad: The Drugs Controller General of India has granted restricted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official sources said on Monday. The DCGI's approval comes after the Subject Expert Committee on COVID-19 of the CDSCO on February 14 recommended granting restricted EUA to Corbevax …

India Age Covid Group Dcgi Clinical Restricted

2 years, 10 months ago

DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group

Firstpost

This is the third vaccine to have received EUA from the DCGI for the age group of 12-18 years after Zydus Cadila’s ZyCoV-D and Bharat Biotech’s Covaxin New Delhi: The Drugs Controller General of India has granted restricted emergency use authorisation to Biological E’s COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official …

India Age Covid Group Cdsco Biological Vaccine

2 years, 10 months ago

Bharat Biotech gets approval for intranasal Covid-19 booster dose trials

India TV News

Highlights Intranasal vaccine will be administered to those who have already taken their two-dose vaccine The interval between the second dose of Covid vaccine and booster dose will be six months According to Bharat Biotech, its nasal vaccine stimulates immune responses at the site of infection The Drugs Controller General of India has granted permission to Hyderabad-based biotechnology firm Bharat …

Covid Sec Bharat Dcgi Bharat Biotech Nasal Biotech

2 years, 11 months ago

Covishield, Covaxin get govt expert panel's recommendation for regular market approval

India TV News

Highlights A DCGI Committee recommended regular market approval to Covishield and Covaxin Covishield and Covaxin are currently only authorised for emergency use in the country SII and Bharat Biotech submitted applications to DCGI seeking regular market approval An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are …

Singh Expert Sec Approval Bharat Biotech Covaxin Covishield

2 years, 11 months ago

Molnupiravir, oral anti-Covid medicine, set for launch in India; to cost Rs 649 per strip

India TV News

Molnupiravir, the world’s first and only oral antiviral to be approved by the US FDA, UK MHRA and Indian CDSCO for treatment of COVID-19, is set for a launch. Last week, the Drugs Controller General of India, based on the review of clinical data of molnupiravir, approved molnupiravir for treatment of adult patients with Covid-19, with SpO2 > 93% and …

India Launch Drug Dcgi Entod Pharmaceuticals Entod Molnupiravir

2 years, 11 months ago

CDSCO panel recommends emergency use authorisation for SII’s Covovax

India TV News

Highlights An expert panel of CDSCO has recommended emergency use authorization for Covovax. India's central drug authority has recommended granting emergency use authorization to Serum Institute of India's COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, Director, Government, and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller …

India Emergency Application Cdsco Vaccine Dcgi Serum Institute

3 years, 3 months ago

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

The Hindu

The Drugs Controller General of India on September 3 granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said. The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol, they …

Trial Dcgi

3 years, 4 months ago

Proposal to study mixing of Covaxin, Covishield approved by DCGI

India TV News

The Drugs Controller General Of India, India's drug regulator, has approved a proposal for a study to be conducted on the mixing of two COVID-19 vaccines -- Covishield and Covaxin. The aim of the study will be to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- …

India Medical Research Study Vaccine Dcgi Research Icmr Covaxin

3 years, 5 months ago

Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre

India TV News

Mumbai-based pharmaceutical firm Cipla has received the Drugs Controller General of India nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India, the Centre said on Tuesday. In separate communications, Moderna on June 27 informed DCGI that the US government has agreed to donate a certain number of doses of its COVID-19 vaccine through COVAX to India for …

India Vaccines Covid Vaccine Moderna Cipla Dcgi

3 years, 6 months ago

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

India TV News

The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India over the weekend, according to government sources. "We have received the data from the phase III trials," a senior government official confirmed. The phase III data of its vaccine have been questioned various times and that …

India Dcgi Covid Vaccine Bharat Biotech Iii Data

3 years, 6 months ago

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis

Firstpost

The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology in Moscow for developing Sputnik V at its licensed Hadapsar facility New Delhi: The DCGI has granted permission to the Serum Institute of India to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday. The Pune-based …

India Research Pune Institute Dcgi Hadapsar Sputnik

3 years, 6 months ago

Serum Institute gets nod to manufacture Russian Sputnik V vaccine in India

India TV News

In what will give a major boost to India's massive vaccination drive, the Serum Institute of India has been cleared to manufacture Russian Sputnik V Covid vaccine in India. Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. "The DCGI has granted permission to the …

India Russia Institute Vaccine Dcgi Sputnik Serum Institute

3 years, 6 months ago

Serum institute seeks permission to manufacture Sputnik V vaccine in India

Firstpost

SII said it will be able to manufacture and supply 10 crore Covishield doses in June while also manufacturing Novavax. The Serum Institute of India has applied to the Drug Controller General of India seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. “The Serum Institute of India put up an application to the …

India Vaccine Serum Dcgi Serum Institute Sii Manufacture

3 years, 6 months ago

Serum Institute Gets DCGI's Nod to Manufacture Covid Jab Sputnik V in India

News 18

The DCGI has granted permission to the Serum Institute of India to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday. The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has …

India Institute Dcgi Sputnik Serum Institute Sii Sputnik V

3 years, 6 months ago

Serum Institute applies to DCGI to manufacture Covid-19 vaccine Sputnik V in India

India Today

Pune-based Serum Institute of India has applied to the Drug Controller General of India seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, government sources said on Thursday. "The Serum Institute of India put up an application to the Drugs Controller General of India on Wednesday seeking permission to manufacture the Covid-19 vaccine, Sputnik V, in India," a …

India Russia Dcgi Serum Institute Sii Manufacture Sputnik Vaccine

Filters

Articles for Dcgi, search results for source

Drug regulator suspends manufacturing and selling of Entod pharma's eye drops over unapproved claims

DGCI issues notice to Amazon, Flipkart among other e-pharmacies over sale of drugs without license

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

Indian-made cough syrups did not cause Gambia children deaths, DCGI informs WHO

Govt panel says information shared by WHO inadequate to determine reason for deaths linked to Gambia

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Corbevax gets DCGI nod as Covid-19 booster dose

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

DCGI grants restricted EUA to COVID jab Corbevax for 12-18 age group

DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group

Bharat Biotech gets approval for intranasal Covid-19 booster dose trials

Covishield, Covaxin get govt expert panel's recommendation for regular market approval

Molnupiravir, oral anti-Covid medicine, set for launch in India; to cost Rs 649 per strip

CDSCO panel recommends emergency use authorisation for SII’s Covovax

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

Proposal to study mixing of Covaxin, Covishield approved by DCGI

Cipla gets DCGI nod to import Moderna's Covid vaccine for emergency use in India: Centre

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis

Serum Institute gets nod to manufacture Russian Sputnik V vaccine in India

Serum institute seeks permission to manufacture Sputnik V vaccine in India

Serum Institute Gets DCGI's Nod to Manufacture Covid Jab Sputnik V in India

Serum Institute applies to DCGI to manufacture Covid-19 vaccine Sputnik V in India